The role of APRIL in promoting cell cycle progression and drug resistance in multiple myeloma
Recent years have seen a significant improvement in survival for patients with multiple myeloma (MM). Novel agent-based induction regimens have resulted in dramatically high overall response rates, however, the overwhelming majority of patients relapse and MM remains incurable. Furthermore, MM shows...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626064 |